Cargando…
MS3-2 TREATMENT STRATEGY BASED ON THE RESULTS OF GENE PANELS
The advance of next-generation sequencers (NGS) has dramatically improved the performance of genomic analysis of clinical samples in cancer precision medicine. The practical use of gene panel testing for clinical applications has begun in Japan. At present, “OncomineTM Dx Target Test” is listed as a...
Autor principal: | Takeda, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213451/ http://dx.doi.org/10.1093/noajnl/vdz039.012 |
Ejemplares similares
-
MS3-1 IMPLEMENTATION OF GENE PANEL TESTING USING NEXT-GENERATION SEQUENCING
por: Sakai, Kazuko
Publicado: (2019) -
729. Improved Detection of Adenovirus with the FilmArray Respiratory Panel 2 Panel in a Pediatric Population
por: Everhart, Kathy, et al.
Publicado: (2018) -
MS-1 Surgical strategy for brain tumor based on molecular and functional connectomics profiles
por: Abe, Tatsuya
Publicado: (2020) -
1091. Algorithmic Release of Clostridium difficile PCR Results From a Multiplex Gastrointestinal (GI) Panel in Children <3 Years Old
por: Hecht, Shaina, et al.
Publicado: (2018) -
MS2 BRAIN TUMORS AND EPILEPSY
por: Iuchi, Toshihiko
Publicado: (2019)